The Safety Assurance Factors for EHR Resilience (SAFER) guides are designed to help healthcare organizations conduct proactive self-assessments to evaluate the safety and effectiveness of their electronic health record (EHR) implementations.
Healthcare providers nationwide have spent billions of dollars adopting electronic health records (EHRs) that incorporate clinical decision support (CDS) to improve patient safety, reduce costs, and comply with federal regulations, but evaluations of CDS implementations have not consistently reported improved patient outcomes or lower costs. Alerts that prompt clinicians about […]
Despite consensus for certain CPOE best practices in the medical literature and among experts, there appeared to be considerable variation among CMIOs’ opinions of best practices.
Our study of quality and safety control processes used for HIT by two leading health care systems shows that resilient safety practices are an important part of safety in complex sociotechnical systems.
Unexpected downtimes related to EHRs appear to be fairly common among institutions in our survey.
The same technique was successfully employed at the University of Texas and accuracy was comparable to our previous results. Top associations included many medications that are highly specific for a particular problem as well as a large number of common, accurate medication-problem pairs that reflect practice patterns.
Using health IT to improve safety is a shared responsibility (44), and by using the SAFER Reporting Framework, researchers can help to enhance the understanding of implementation, effectiveness, and generalizability of EHR-based interventions needed to effectively reduce preventable harm.
The COVID-19 pandemic has highlighted the need for more effective solutions for gathering health data at a national level.
This qualitative study found that usability of the EHR inbox is often suboptimal and variable across sites, suggesting lack of shared best practices related to information management.
Organizations should improve the options available to providers who choose to override drug-drug interaction (DDI) alerts. We found wide variability in override reasons and many opportunities to improve alerts.
